Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations - PubMed (original) (raw)
. 1991 Apr 1;77(7):1508-15.
Affiliations
- PMID: 2009370
Free article
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations
K Offit et al. Blood. 1991.
Free article
Abstract
Cytogenetic and histopathologic data were correlated with clinical parameters from 423 patients with non-Hodgkin's lymphoma (NHL). Clinical correlations were performed on subgroups of 149 patients with low-grade lymphoma (LG) and 205 patients with diffuse lymphoma with a large cell component (DLLC). Correlations were made between clinical outcome and individual recurring cytogenetic aberrations, each of which was noted in greater than 5% of cases belonging to LG NHL and DLLC, and derived measures of karyotypic complexity, comprising modal chromosome number, number of marker chromosomes, and number of translocation breakpoints. No correlations with survival were noted in LG NHL, although median follow-up was only 2 years. Seven patients with t(8;14) LG NHL had an indolent course. Among 104 patients with DLLC and abnormal karyotypes at diagnosis, breaks at 1q21-23 or more than 4 marker chromosomes was associated with a shortened median survival. Using these variables we constructed a proportional hazards model with a good fit to observed data. Breaks at 6q21-25 predicted a decreased probability of achieving remission. Patients with DLLC and breaks at 1q21-23 or 1p32-36 had a shorter duration of complete remission. Of 41 DLLC studied at relapse, the only long-term survivors had t(14;18).
Similar articles
- Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RS. Offit K, et al. Genes Chromosomes Cancer. 1991 May;3(3):189-201. doi: 10.1002/gcc.2870030304. Genes Chromosomes Cancer. 1991. PMID: 1868033 - Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.
Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T, Longo DL. Whang-Peng J, et al. Blood. 1995 Jan 1;85(1):203-16. Blood. 1995. PMID: 7803794 - Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.
Offit K, Parsa NZ, Jhanwar SC, Filippa D, Wachtel M, Chaganti RS. Offit K, et al. Genes Chromosomes Cancer. 1993 May;7(1):1-7. doi: 10.1002/gcc.2870070102. Genes Chromosomes Cancer. 1993. PMID: 7688550 - Cytogenetics of non-Hodgkin's lymphoma.
Levine EG, Bloomfield CD. Levine EG, et al. J Natl Cancer Inst Monogr. 1990;(10):7-12. J Natl Cancer Inst Monogr. 1990. PMID: 2189479 Review. - Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations.
Offit K, Chaganti RS. Offit K, et al. Hematol Oncol Clin North Am. 1991 Oct;5(5):853-69. Hematol Oncol Clin North Am. 1991. PMID: 1938758 Review.
Cited by
- Challenging perspectives on the cellular origins of lymphoma.
Malcolm TI, Hodson DJ, Macintyre EA, Turner SD. Malcolm TI, et al. Open Biol. 2016 Sep;6(9):160232. doi: 10.1098/rsob.160232. Open Biol. 2016. PMID: 27683157 Free PMC article. - Molecular pathology in the diagnosis and treatment of non-Hodgkin's lymphomas.
Krause JR, Shahidi-Asl M. Krause JR, et al. J Cell Mol Med. 2003 Oct-Dec;7(4):494-512. doi: 10.1111/j.1582-4934.2003.tb00254.x. J Cell Mol Med. 2003. PMID: 14754520 Free PMC article. Review. - Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A, Ott G. Horn H, et al. Haematologica. 2011 Sep;96(9):1327-34. doi: 10.3324/haematol.2011.042531. Epub 2011 Jun 9. Haematologica. 2011. PMID: 21659362 Free PMC article. - bax, but not bcl-2, influences the prognosis of human pancreatic cancer.
Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM, Büchler MW. Friess H, et al. Gut. 1998 Sep;43(3):414-21. doi: 10.1136/gut.43.3.414. Gut. 1998. PMID: 9863489 Free PMC article. - Thymic epithelial tumors can develop along two different pathogenetic pathways.
Zhou R, Zettl A, Ströbel P, Wagner K, Müller-Hermelink HK, Zhang S, Marx A, Starostik P. Zhou R, et al. Am J Pathol. 2001 Nov;159(5):1853-60. doi: 10.1016/s0002-9440(10)63031-3. Am J Pathol. 2001. PMID: 11696445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials